time prolongation streptokinase reduction vasopressin mechanism treatment thrombolytic agents bleeding frequency events bleeding time individuals aspirin effects streptokinase IU/kg time rabbits aspirin model fibrinolytic therapy effects vasopressin DDAVP microgram/kg agent time variety disorders rabbits results control group rabbits normal saline placebo Aspirin bleeding time baseline mean SEM value seconds control group seconds experimental group addition streptokinase bleeding time seconds control group seconds experimental group NS Subsequent infusion DDAVP bleeding time experimental group seconds versus streptokinase seconds NS streptokinase control animals saline placebo subset rabbits aspirin streptokinase IU/kg samples platelet aggregation von Willebrand factor antigen concentration von Willebrand factor multimer distribution Maximal rates ADP-induced platelet aggregation DDAVP infusion plasma concentration von Willebrand factor antigen immunoradiometric assay DDAVP infusion von Willebrand factor multimer ratio DDAVP administration findings aspirin streptokinase result marked increase time DDAVP effect DDAVP increase platelet aggregation response plasma von Willebrand factor antigen concentration von Willebrand factor multimer ratio 